Amniotic Fluid Lactate in Perterm Premature Rupture of Membranes

Rupture of Membranes; Premature Clinical Trial

Official title:

Amniotic Fluid Lactate in Predicting Latency in Perterm Premature Rupture of Membranes

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03789903
• Other study ID #: ain shams maternity hos
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2018
• Est. completion date: March 1, 2019

Study information

• Verified date: December 2018
• Source: Ain Shams University
• Contact: Radwa R Ali, MD
• Phone: 01283492979
• Email: radwaebed[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

AF lactate level could help in predicting the duration from ROM till delivery

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 80
• Est. completion date: March 1, 2019
• Est. primary completion date: January 1, 2019
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 25 Years to 35 Years

Eligibility

Inclusion Criteria:

1. women with PPROM

2. GA between 24 to 34 weeks

Exclusion Criteria:

1. chorioamnionitis

2. previous Preterm labor

3. abruptio placentae

4. UTI ,pyelonephritis

Related Conditions & MeSH terms

• Fetal Membranes, Premature Rupture
• Premature Birth
• Rupture
• Rupture of Membranes; Premature

Intervention

Diagnostic Test:
• amniotic fluid lactate
AF lactate

Locations

Country	Name	City	State
Egypt	AinShams university maternity hospital	Cairo	Abbassya

Sponsors (1)

Lead Sponsor	Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	latency period	duration from ROM till the occurrence of active labor	upto 48 hours